Mutational signatures shift induced by chemotherapeutic agents, 5-Fluorouracil and Oxaliplatin, in the gut microbiome
Fei Su(Bengbu Medical College), Fei Xiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Hexin Li(Beijing Hospital), Qingfeng Luo(Dalian Medical University), Jie Ma(Tianjin University of Traditional Chinese Medicine), Min Tang(Ningbo No. 2 Hospital), Yingying Huang(Nanfang Hospital), Meng Chen(University of Washington), Zhao Liu(Shanghai University of Traditional Chinese Medicine), Xue Xu(Sun Yat-sen University), Yunbo Zhao(University of Science and Technology of China), Lin Li(Fujian Medical University), Hongtao Xu(Wenzhou Medical University), Gang Zhao(Xijing Hospital), Bin Ai(Beijing Hospital), Wenzhuo Jia(Beijing Hospital), Lihui Zou(Beijing Hospital)
Cited by 1
Related Papers
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
|Nature|2010|1.8k
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.8k
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study
|The Lancet|2019|773
Novel Strategies for the Prevention and Treatment of Biofilm Related Infections
|International Journal of Molecular Sciences|2013|425